查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824228

次世代定序市场 - 预测 2025-2030

Next Generation Sequencing Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

次世代定序市场规模：

预计次世代定序市场将从 2025 年的 166.96 亿美元成长到 2030 年的 367.78 亿美元，复合年增长率为 17.11%。

次世代定序(NGS) 是一项革命性的平行定序技术，具有卓越的扩充性、速度和超高通量能力。这项尖端技术能够测定完整基因组或 RNA 或 DNA 目标区域的核苷酸序列，从根本上推动生物科学的现代化，使实验室能够在多个层面研究生物系统并进行多样化的应用。

技术能力和优势

NGS 为复杂的基因组研究提供了全面的解决方案，突破了传统 DNA 定序技术的限制。此技术能够实现快速全基因组定序、标靶区域深度定序、用于发现新型 RNA 变异和剪接位点的 RNA 定序 (RNA-Seq)，以及用于基因表现分析的 mRNA 定量。这些功能使 NGS 成为解决超越传统定序方法能力的高阶基因组学问题的重要工具。

NGS平台的演进带来了高效、可携式且用户友好的系统，能够快速提供准确的结果。这些技术改进提高了可访问性和操作效率，促进了其在研究和临床应用中的广泛应用。

市场成长动力

扩大应用范围

NGS 在各研究领域的应用日益广泛，推动着市场需求的持续成长。基因组图谱计画的加强和合作研究伙伴关係关係的建立，带来了大量的研发投入，为市场扩张奠定了坚实的基础。 NGS 技术的多功能性使其能够应用于从基础研究到临床诊断的多个生物研究领域。

政府和私人投资

政府和私营部门对研发项目的大量投资正在支撑市场成长，尤其是在新兴经济体，这些国家高度重视基因研究和疾病认知的进步。政府机构正在积极参与测序项目，以寻找癌症和其他疾病的改进治疗方法。此类支援有利于新参与企业进入市场，并为现有参与企业创造成长机会。

广泛的政府和私人支援正在推动 NGS 设备的采用，扩大必要耗材的取得管道，并支持多个地区的整体市场发展。

技术平台进步

持续的技术进步正在推动更有效率、可携式、更便利的NGS平台的开发。这些进步正在推动整个产业的研发倡议，同时也为主要企业提供了竞争优势。用户友好、准确性和速度更高的系统的推出正在扩大潜在的用户群和应用程式场景。

市场限制与挑战

技术人员有限

合格专业人员的短缺是市场的主要限制因素。能够解读复杂NGS数据的技术人员数量有限，阻碍了研究进展和产业发展。这种技能差距尤其影响开发中国家的技术专长较为匮乏，阻碍了该技术的采用和有效使用。

研发经费挑战

研发资金限制对市场发展构成持续挑战，尤其是在新兴经济体。许多研究机构和学术组织面临预算限制，无法购买先进且昂贵的NGS设备和技术。这种对外部资金的依赖带来了不确定性，并可能限制资源受限地区的市场扩张。

解释 NGS 平台产生的复杂数据需要专业知识和大量时间投入，这会带来操作挑战，从而减缓研究进度和技术采用率。

战略意义

在应用扩展、政府支持和技术进步的推动下，NGS市场展现出强劲的成长潜力。然而，要想取得成功，必须透过全面的培训计画和技术简化措施来解决技术人才的不足。市场参与企业必须在先进能力建设与可近性之间取得平衡，以最大限度地涵盖不同的研究环境和地理区域，同时帮助培养本地专业知识和基础设施。

本报告的主要优点

  • 深刻分析：获得深入的市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业所采用的策略策略，并了解采用正确策略的市场渗透潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说，既有利又划算。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 分析范围
  • 细分市场

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章次世代定序市场：依产品分类

  • 介绍
  • 硬体
  • 软体和服务

第六章次世代定序市场：依类型

  • 介绍
  • 基因组序列分析
  • EXOME定序
  • 标靶定序

第七章次世代定序市场（依方法）

  • 介绍
  • 边合成边定定序（SBS）
  • 离子半导体定序
  • 奈米孔定序
  • 其他的

第八章次世代定序市场（按应用）

  • 介绍
  • 瘤
  • 感染疾病诊断
  • 药物发现与开发
  • 其他的

第九章次世代定序市场（依最终用户）

  • 介绍
  • 医院和诊所
  • 学术研究机构
  • 製药和生物技术公司
  • 其他的

第 10 章按地区分類的次世代定序市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十一章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪表板

第十二章：公司简介

  • F. Hoffmann-La Roche AG
  • Agilent Technologies
  • Illumina, Inc.
  • Thermo Fisher Scientific.
  • Macrogen, Inc
  • BGI Group
  • Qiagen
  • DNASTAR
  • Pacific Biosciences of California, Inc.
  • Bio-Rad Laboratories, Inc.

第十三章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称

图表列表

表格列表

简介目录
Product Code: KSI061610956

Next Generation Sequencing Market Size:

The next generation sequencing market is expected to grow from USD 16.696 billion in 2025 to USD 36.778 billion in 2030, at a CAGR of 17.11%.

Next-generation sequencing (NGS) represents a transformative parallel sequencing technology that delivers exceptional scalability, speed, and ultra-high throughput capabilities. This advanced technology determines nucleotide sequences in complete genomes or targeted regions of RNA or DNA, fundamentally modernizing biological sciences and enabling laboratories to conduct diverse applications while studying biological systems across multiple levels.

Technology Capabilities and Advantages

NGS addresses the limitations of traditional DNA sequencing technologies by providing comprehensive solutions for complex genomics research. The technology enables rapid whole genome sequencing, deep sequencing of targeted regions, RNA sequencing (RNA-Seq) for discovering novel RNA variants and splice sites, and mRNA quantification for gene expression analysis. These capabilities position NGS as an essential tool for addressing advanced genomics questions that exceed the capacity of conventional sequencing methods.

The evolution of NGS platforms has introduced efficient, portable, and user-friendly systems capable of delivering rapid and accurate results. These technological improvements have enhanced accessibility and operational efficiency, contributing to widespread adoption across research and clinical applications.

Market Growth Drivers

Expanding Application Scope

The increasing application of NGS across diverse research areas drives sustained market demand. Enhanced genome mapping programs and collaborative partnerships result in significant R&D investments, creating a robust foundation for market expansion. The versatility of NGS technology enables its deployment across multiple biological research domains, from basic research to clinical diagnostics.

Government and Private Sector Investment

Substantial investments from both government and private sectors in research and development programs support market growth, particularly in developing countries focused on advancing genetic research and disease understanding. Government organizations actively participate in sequencing programs to identify improved treatment approaches for cancer and other diseases. This support facilitates market entry for new participants and creates growth opportunities for established industry players.

The widespread governmental and private backing has led to increased adoption of NGS instruments and expanded utilization of required consumables, supporting overall market development across multiple geographic regions.

Technological Platform Advancement

Continuous technological improvements have resulted in more efficient, portable, and accessible NGS platforms. These advancements provide competitive advantages to prominent companies while encouraging research and development initiatives throughout the industry. The introduction of user-friendly systems with enhanced accuracy and speed capabilities has broadened the potential user base and application scenarios.

Market Constraints and Challenges

Skilled Personnel Limitations

The shortage of qualified professionals represents a significant market constraint. The limited availability of skilled personnel capable of interpreting complex NGS data creates bottlenecks in research progress and industry growth. This skills gap particularly affects developing nations where technical expertise may be less readily available, hindering technology adoption and effective utilization.

Research and Development Funding Challenges

Financial constraints in research and development, particularly in developing economies, present ongoing market challenges. Many research institutions and academic organizations face budget limitations that prevent acquisition of advanced, premium-priced NGS equipment and technologies. This funding dependency on external sources creates uncertainty and may limit market expansion in regions with constrained financial resources.

The interpretation of complex data generated by NGS platforms requires specialized expertise and significant time investment, creating operational challenges that may slow research progress and technology adoption rates.

Strategic Implications

The NGS market demonstrates strong growth potential driven by expanding applications, government support, and technological advancement. However, success requires addressing skilled personnel limitations through comprehensive training programs and technology simplification initiatives. Market participants must balance advanced capability development with accessibility considerations to maximize adoption across diverse research environments and geographic regions while supporting the development of local expertise and infrastructure.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Next Generation Sequencing Market Segments:

By Offerings

  • Hardware
  • Software & Services

By Type

  • Genome Sequencing
  • Exome Sequencing
  • Targeted Sequencing

By Method

  • Sequencing By Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Others

By Application

  • Oncology
  • Infectious Disease Diagnostics
  • Drug Discovery & Development
  • Others

By End-Users

  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotech Companies
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEXT GENERATION SEQUENCING MARKET BY OFFERINGS

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Software & Services

6. NEXT GENERATION SEQUENCING MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Genome Sequencing
  • 6.3. Exome Sequencing
  • 6.4. Targeted Sequencing

7. NEXT GENERATION SEQUENCING MARKET BY METHOD

  • 7.1. Introduction
  • 7.2. Sequencing By Synthesis (SBS)
  • 7.3. Ion Semiconductor Sequencing
  • 7.4. Nanopore Sequencing
  • 7.5. Others

8. NEXT GENERATION SEQUENCING MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Oncology
  • 8.3. Infectious Disease Diagnostics
  • 8.4. Drug Discovery & Development
  • 8.5. Others

9. NEXT GENERATION SEQUENCING MARKET BY END-USERS

  • 9.1. Introduction
  • 9.2. Hospitals & Clincs
  • 9.3. Academic & Research Institutes
  • 9.4. Pharmaceutical & Biotech Companies
  • 9.5. Others

10. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. USA
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. Middle East and Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Israel
    • 10.5.4. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. India
    • 10.6.3. Japan
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Thailand
    • 10.6.7. Taiwan
    • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. F. Hoffmann-La Roche AG
  • 12.2. Agilent Technologies
  • 12.3. Illumina, Inc.
  • 12.4. Thermo Fisher Scientific.
  • 12.5. Macrogen, Inc
  • 12.6. BGI Group
  • 12.7. Qiagen
  • 12.8. DNASTAR
  • 12.9. Pacific Biosciences of California, Inc.
  • 12.10. Bio-Rad Laboratories, Inc.

13. APPENDIX

  • 13.1. Currency
  • 13.2. Assumptions
  • 13.3. Base and Forecast Years Timeline
  • 13.4. Key benefits for the stakeholders
  • 13.5. Research Methodology
  • 13.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES